| Randomized intergroup trial of cisplatin–paclitaxel versus cisplatin–cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results MJ Piccart, K Bertelsen, K James, J Cassidy, C Mangioni, E Simonsen, ... Journal of the National Cancer Institute 92 (9), 699-708, 2000 | 1306 | 2000 |
| Duration of adjuvant chemotherapy for stage III colon cancer A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ... New England Journal of Medicine 378 (13), 1177-1188, 2018 | 954 | 2018 |
| Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis AJ Mitchell, DW Ferguson, J Gill, J Paul, P Symonds The lancet oncology 14 (8), 721-732, 2013 | 871 | 2013 |
| Phase III randomized trial of docetaxel–carboplatin versus paclitaxel–carboplatin as first-line chemotherapy for ovarian carcinoma PA Vasey, GC Jayson, A Gordon, H Gabra, R Coleman, R Atkinson, ... Journal of the National Cancer Institute 96 (22), 1682-1691, 2004 | 794 | 2004 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 651 | 2013 |
| Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer CA Espie, L Fleming, J Cassidy, L Samuel, LM Taylor, CA White, ... Journal of clinical oncology 26 (28), 4651-4658, 2008 | 467 | 2008 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 424 | 2013 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 421 | 2017 |
| Copy number signatures and mutational processes in ovarian carcinoma G Macintyre, TE Goranova, D De Silva, D Ennis, AM Piskorz, M Eldridge, ... Nature genetics 50 (9), 1262-1270, 2018 | 393 | 2018 |
| The Acquisition of hMLH1 Methylation in Plasma DNA after Chemotherapy Predicts Poor Survival for Ovarian Cancer Patients G Gifford, J Paul, PA Vasey, SB Kaye, R Brown, ... Clinical cancer research 10 (13), 4420-4426, 2004 | 348 | 2004 |
| Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the … PS Roshanov, B Rochwerg, A Patel, O Salehian, E Duceppe, ... Anesthesiology 126 (1), 16-27, 2017 | 310 | 2017 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 310 | 2015 |
| Common variants at 19p13 are associated with susceptibility to ovarian cancer KL Bolton, J Tyrer, H Song, SJ Ramus, M Notaridou, C Jones, T Sher, ... Nature genetics 42 (10), 880-884, 2010 | 297 | 2010 |
| Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer S Marsh, J Paul, CR King, G Gifford, HL McLeod, R Brown Journal of Clinical Oncology 25 (29), 4528-4535, 2007 | 290 | 2007 |
| Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial SC Crawford, PA Vasey, J Paul, A Hay, JA Davis, SB Kaye Journal of clinical oncology 23 (34), 8802-8811, 2005 | 263 | 2005 |
| Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes G Strathdee, K Appleton, M Illand, DWM Millan, J Sargent, J Paul, ... The American journal of pathology 158 (3), 1121-1127, 2001 | 248 | 2001 |
| PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ... Journal of medical genetics 53 (12), 800-811, 2016 | 242 | 2016 |
| Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer SB Kaye, CR Lewis, J Paul, M Soukop, EM Rankin, J Cassidy, JA Davis, ... The Lancet 340 (8815), 329-333, 1992 | 237 | 1992 |
| Bridging the special education divide JE Andrews, DW Carnine, MJ Coutinho, EB Edgar, SR Forness, LS Fuchs, ... Remedial and Special education 21 (5), 258-267, 2000 | 233 | 2000 |
| A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma N O’Rourke, JC Garcia, J Paul, C Lawless, R McMenemin, J Hill Radiotherapy and oncology 84 (1), 18-22, 2007 | 223 | 2007 |
